Can the participation in a cardiac exercise group for patients with severe heart disease improve quality of life, social participation and physical as well as cognitive performance?: a longitudinal pilot study

Can the participation in a cardiac exercise group for patients with severe heart disease improve quality of life, social participation and physical as well as cognitive performance?: a longitudinal pilot study - Scientific monitoring of a cardiac exercise group

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033561

Enrollment

Registered

2024-02-15

Start date

2024-02-28

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50 I50.0 I27.0 I47.2 I46.0 I42 I42.1 I34 I35 I36

Interventions

Group 1: Intervention group (once weekly participation of 60 minutes in a supervised cardiac exercise group)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: At least one of the following possible diagnoses: - Heart failure with shortness of breath on exertion (LVEF < 40%, NYHA II-III) - Severe right heart failure - Recurrent/persistent ventricular arrhythmia - Moderately severe symptomatic valvular heart disease - Survival of sudden cardiac death in the 1st year with ICD/survived cardiac arrest - Hypertrophic (obstructive) cardiomyopathy with/without ICD - Body weight < 150 kg - Participants must be able to ride the bicycle ergometer - Ability to walk, if necessary with aids, must be given

Exclusion criteria

Exclusion criteria: Participants are excluded who - are unable to understand the study information or give written consent due to cognitive or visual impairments. - have insufficient German language skills to understand the information and survey instruments.

Design outcomes

Primary

Measure	Time frame
Quality of life and health status (EQ-5D-5L; EQ VAS), social participation (IMET questionnaire), functional (hand strength, 6-minute walk test) and cognitive performance (MoCa test, puzzle test, self-reported subjective memory impairment), sarcopenia status (SARC-F questionnaire), anxiety and depression (HADS questionnaire) as well as sport and exercise-related motivation (SSK scale) after 12 months	—

Measure

Time frame

Quality of life and health status (EQ-5D-5L; EQ VAS), social participation (IMET questionnaire), functional (hand strength, 6-minute walk test) and cognitive performance (MoCa test, puzzle test, self-reported subjective memory impairment), sarcopenia status (SARC-F questionnaire), anxiety and depression (HADS questionnaire) as well as sport and exercise-related motivation (SSK scale) after 12 months

—

Secondary

Measure	Time frame
socio-demographic data (e.g., gender, education), clinical data (e.g., including height, weight, BMI), frailty status (Clinical Frailty Scale), activity of daily living (IPAQ questionnaire)	—

Countries

Germany

Contacts

Public ContactStephanie Heinemann

Universitätsmedizin Göttingen, Klinik für Geriatrie

stephanie.heinemann@med.uni-goettingen.de0049 551 39 65391

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026